Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: A retrospective analysis

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 1, 2010, Pages 77-84

  Cirasino, Lorenzo ^a,b   Robino, Anna M ^a,b   Cattaneo, Marco ^c   Pioltelli, Pietro E ^d   Pogliani, Enrico M ^d   Terranova, Laura ^c   Morra, Enrica ^a   Colombo, Paola ^a   Palmieri, Giancarlo A ^a,b   Piscitelli, Prisco ^e  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b Divisioni di Ematologia ^*  (Italy)

^c SAN PAOLO HOSPITAL   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

^e Istituto Scientifico Biomedico Euro Mediterraneo (ISBEM)   (Italy)

Author keywords

Appropriateness; Immune thrombocytopenic purpura; Management

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN;

ADULT; ARTICLE; BLEEDING; CHEMOPROPHYLAXIS; CORTICOSTEROID THERAPY; DRUG MEGADOSE; ELECTIVE SURGERY; FEMALE; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MUCOSAL BLEEDING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PURPURA; RETROSPECTIVE STUDY; SPLENECTOMY; SURGICAL INFECTION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; VAGINA BLEEDING;

ADULT; ANTIBIOTIC PROPHYLAXIS; COMBINED MODALITY THERAPY; DISEASE MANAGEMENT; FEMALE; GLUCOCORTICOIDS; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; ITALY; MALE; MEDICAL AUDIT; MIDDLE AGED; PATIENT ADMISSION; PLATELET TRANSFUSION; PRACTICE GUIDELINES AS TOPIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; SPLENECTOMY; UNNECESSARY PROCEDURES; YOUNG ADULT;

EID: 75649152891     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328332dbb6     Document Type: Article

References (26)

1. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346:995-1008.
2. Scwartz RS. Immune thrombocytopenic purpura: from agony to agonist. N Engl J Med 2007; 357:2299-2301.
3. Ruggeri M, Fortuna S, Rodeghiero F. Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature. Haematologica 2008; 93:98-103.
4. Fogarty PF, Segal JB. The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol 2007; 14:515-519.
5. Neylon AJ, Saunders PWG, Howard MR, Proctor SJ, Taylor PR, Northern Region Haematology Group. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 2003; 122:966-974.
6. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardizations of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children. Report from an international working group. Blood 2009; 113:2386-2393.
7. Beardsley DS. ITP in the 21st century. Hematology Am Soc Hematol Educ Program 2006; 2006:402-407.
8. Bolton-Maggs PHB, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 1997; 350:620-623.
9. Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 1999; 94:909-913.
10. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.
11. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120:574-596.
12. Andemariam B, Psaila B, Bussel JB. Novel thrombopoietic agents. Hematology Am Soc Hematol Educ Program 2007; 2007:106-113.
13. Cheng Y, Wong RSM, Soo YOY, Chui CH, Lau FY, Chan NP, et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med 2003; 349:831-836.
14. Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, et al. Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. Blood 2007; 109:1401-1407.
15. Garcia-Chavez J, Majluf-Cruz A, Montiel-Cervantes L, Esparza MG, Vela- Ojeda J, Mexican Hematology Study Group. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis. Ann Hematol 2007; 86:871-877.
16. Schweizer C, Reu FJ, Ho AD, Hensel M. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Ann Hematol 2007; 86:711-717.
17. Provan D, Butler T, Evangelista ML, Amadori S, Newland AC, Stasi R. Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults. Haematologica 2007; 92:1695-1698.
18. Zaja F, Battista ML, Pirrotte MT, Palmieri S, Montagna M, Vianelli N, et al. Lower dose rituximab is active in adult patients with idiopathic thrombocytopenic purpura. Haematologica 2008; 93:930-933.
19. Bader-Meunier B, Aladjidi N, Bellmann F, Monpoux F, Nelken B, Robert A, et al. Rituximab therapy for childhood Evans syndrome. Haematologica 2007; 92:1691-1694.
20. Gaines AR. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rho(D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood 2005; 106:1532-1537.
21. Bussel JB, Cheng G, Saleh MN, Psaila B, Kovaleva L, Meddeb B, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007; 357:2237-2247.
22. Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost 2006; 4:2377-2383.
23. Liebman HA, Stasi R. Secondary immune thrombocytopenic purpura. Curr Opin Hematol 2007; 14:557-573.
24. Liebman HA. Viral-associated immune thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2008; 2008:212-218.
25. Vianelli N, Galli M, de Vivo A, Intermesoli T, Giannini B, Mazzucconi MG, et al. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica 2005; 90:72-77.
26. Godeau B, Chevret S, Varet B, Lefrè re F, Zini JM, Bassompierre F, et al. Intravenous immunoglobulin or high-dose methylprednisolone, with or without prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet 2002; 359:23-29.